Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4BOEHRINGER INGELHEIM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmex
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 10406172

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212614

Patent Use Code : U-2733

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-15

blank

02

arrow
Pharmex
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 10406172

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212614

Patent Use Code : U-2733

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-15

blank

03

arrow
Pharmex
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 10406172

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212614

Patent Use Code : U-2733

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-15

blank

04

arrow
Pharmex
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 10406172

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212614

Patent Use Code : U-2733

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-15

blank